# Junta clínica — PT-pseudo_668c2a174afc (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_668c2a174afc",
  "pid": "PT-pseudo_668c2a174afc",
  "task": 1,
  "psa": 7.93,
  "age": 74,
  "months": 3,
  "pirads": "5",
  "psad": 0.267,
  "psav": 1.17,
  "psap": 5.7,
  "vol": 29.7,
  "dre": "Normal",
  "bx": "None",
  "cspca": 0.72964996,
  "medhx": "Not reported",
  "meds": "None",
  "notes": "PSA 7.93 ng/mL. PI-RADS 5. PSAD 0.27. Prostate volume 30 mL. csPCa 0.73.",
  "pmhx": [],
  "allergies": [],
  "vitals": {
    "weight": "64 kg",
    "height": "174 cm",
    "bmi": "21.1",
    "bp": "141/69 mmHg",
    "hr": "80 bpm",
    "smoking": "Non-smoker",
    "last_dental": "1 yr ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "22 Jan 2025",
  "enc_ref": "Dr. F. de Boer (GP)",
  "enc_type": "Follow-up - PSA + MRI",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Current assessment focuses on interpreting the most recent multiparametric MRI alongside updated PSA metrics."
    },
    {
      "s": "History",
      "t": "At seventy-four years of age, this retired bank clerk is divorced and shares a household with his partner. He maintains a strict non-smoker status and abstains completely from alcohol, supplementing that routine with light home-based resistance training twice weekly. Medical history reveals zero comorbidities and no active prescriptions. Lower urinary tract symptoms are entirely absent, registering a zero IPSS score, while he explicitly denies erectile dysfunction or hematuria. Routine health maintenance includes biannual dental examinations, a dermatology screening last month for actinic keratosis surveillance, and the recent completion of a six-session physiotherapy program targeting stable mechanical lower back pain. Travel to this facility necessitates a train commute exceeding one hour. Prior biopsy history registers as negative."
    },
    {
      "s": "Physical examination",
      "t": "Digital rectal examination demonstrates a symmetrically smooth gland with uniform consistency and absolutely no palpable asymmetry or discrete nodularity. Vital signs remain stable, and general inspection shows a well-appearing gentleman free of acute distress. Palpation of the abdomen yields a soft, non-tender contour with no detectable masses or lymphadenopathy."
    }
  ],
  "occupation": "retired bank clerk",
  "marital": "Divorced",
  "living": "Lives with partner",
  "next_of_kin": "Spouse / partner (primary contact)",
  "recent_other": [
    "Dental — biannual check-up",
    "Physiotherapy — lower back, six sessions",
    "Dermatology — actinic keratosis check"
  ],
  "alcohol": "0 units / week (alcohol-free)",
  "exercise": "Light weight-training at home, 2x/week",
  "ipss": "IPSS score: 0/35 (mild LUTS)",
  "admin": "Patient travels 60+ min by train to clinic; allow buffer.",
  "mri_hospital": "Amsterdam UMC (location VUmc)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_668c2a174afc
Task: 1

Encounter: Urology - outpatient on 22 Jan 2025.
Referrer: Dr. F. de Boer (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 74-year-old male
  - PSA: 7.93 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.267 ng/mL²
  - PSA velocity: 1.17 ng/mL/yr
  - Prior PSA: 5.7 ng/mL
  - Prostate volume: 29.7 mL
  - Months since last PSA: 3
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.72964996 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 7.93 ng/mL. PI-RADS 5. PSAD 0.27. Prostate volume 30 mL. csPCa 0.73.

Vitals: weight 64 kg, height 174 cm, BMI 21.1, BP 141/69 mmHg, HR 80 bpm. Smoking: Non-smoker.

Chief complaint: Current assessment focuses on interpreting the most recent multiparametric MRI alongside updated PSA metrics.

History: At seventy-four years of age, this retired bank clerk is divorced and shares a household with his partner. He maintains a strict non-smoker status and abstains completely from alcohol, supplementing that routine with light home-based resistance training twice weekly. Medical history reveals zero comorbidities and no active prescriptions. Lower urinary tract symptoms are entirely absent, registering a zero IPSS score, while he explicitly denies erectile dysfunction or hematuria. Routine health maintenance includes biannual dental examinations, a dermatology screening last month for actinic keratosis surveillance, and the recent completion of a six-session physiotherapy program targeting stable mechanical lower back pain. Travel to this facility necessitates a train commute exceeding one hour. Prior biopsy history registers as negative.

Physical examination: Digital rectal examination demonstrates a symmetrically smooth gland with uniform consistency and absolutely no palpable asymmetry or discrete nodularity. Vital signs remain stable, and general inspection shows a well-appearing gentleman free of acute distress. Palpation of the abdomen yields a soft, non-tender contour with no detectable masses or lymphadenopathy.

Patient info: retired bank clerk; Divorced; Lives with partner.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 0 units / week (alcohol-free); exercise Light weight-training at home, 2x/week; IPSS score: 0/35 (mild LUTS).

Recent other appointments: Dental — biannual check-up; Physiotherapy — lower back, six sessions; Dermatology — actinic keratosis check.
Admin: Patient travels 60+ min by train to clinic; allow buffer.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.87
  uncertainty  +/- 0.05 epistemic (95% band 0.78-0.97); among patients I cannot tell apart the outcome was 0.55 of 1.00 mixed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

What moved me most, across the labelled series: prior positive biopsy, PI-RADS >= 4, no prior biopsy, pmhx_hypercholesterolaemia, suspicious DRE, number of comorbidities. I read 39 variables, all
from the panel — nothing from the mpMRI prose, the PSA trajectory, the previous notes or the
laboratory. Out-of-fold over 91 labelled cases: AUC 0.758, balanced
accuracy 0.625.

The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: never biopsied. My criterion answers BIOPSY.

The criterion: sample when the mpMRI shows a PI-RADS 3 or higher lesion; defer at PI-RADS 1-2. In the labelled series this criterion matched the reading urologist in 24 of 24 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 24 labelled men in this same situation (None prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 0.41: PI-RADS 5, PSA 6.77, PSAD 0.239, age 74, DRE Normal -> BIOPSY (clear). He wrote: "74yr where it was decided to do MRI to assess potential PCa. The MRI shows high suspicion of PCa, and thus should be biopsied. Why was he not biopsied when the first MRI…"
  2. distance 0.90: PI-RADS 5, PSA 12.0, PSAD 0.411, age 71, DRE Normal -> BIOPSY (borderline). He wrote: "P5 in 71 years old patient with no major comorbidities"
  3. distance 1.27: PI-RADS 5, PSA 11.4, PSAD 0.209, age 70, DRE Normal -> BIOPSY (clear). He wrote: "P5 with rapid increasing PSA"

PRECEDENT: BIOPSY (weighted vote 1.00 for biopsy). Distance-weighted precedent is strong here (0.92 leave-one-out).

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 24 labelled traces in this situation (None prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.
WHAT HE WEIGHS: bx=noted, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted.
HOW SURE HE USUALLY IS: clear.

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines suggest that a PI-RADS score of 3 or higher mandates a biopsy. The retrieved text states, "a PI-RADS threshold of $\ge 3$ is used to trigger biopsy [135, 226, 264, 375], at the cost of missing a small number of mainly ISUP GG 2 cancers, especially in biopsy-naïve patients or in highly selected populations with high prevalence of csPCa (in which the MRI NPV decreases) [372, 472]."

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your suggestion of biopsy is contradicted by the cohort criterion which states that the criterion matches the reading urologist in 24 of 24 cases in this exact situation. EXPERT-LIBRARY suggests a biopsy based on a PI-RADS 5 and a rapid PSA increase, which differs from this patient's profile.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the prior biopsy status: None means the indication stands based on the guideline, requiring a decision on whether to proceed.
radiology_report - whether the lesion is compared against an earlier study: this is not specified, but the PI-RADS 5 score is the key finding that triggers the guideline.
psa_trend - the PSA velocity: the velocity of 1.17 ng/mL/yr is a factor that the guideline matrix may use in conjunction with the PI-RADS score.
laboratory_results - the PSA density: the PSAD of 0.267 ng/mL/cc is a factor that the guideline matrix may use in conjunction with the PI-RADS score.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges on whether the PI-RADS 5 score, combined with the PSA velocity, meets the threshold for biopsy according to the EAU guidelines, especially given the precedent suggests a biopsy.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the report specify whether the lesion is compared against an earlier study?
  psa_trend (get_psa_trend) -> What does the PSA velocity of 1.17 ng/mL/yr indicate regarding the decision to biopsy?
  previous_notes (get_previous_notes) -> What is the management context regarding the prior biopsy status (None) and surveillance protocol?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What does the radiology_report state regarding whether the lesion is compared against an earlier study?
  Q2. What does the psa_trend indicate regarding the PSA velocity in the context of the PI-RADS 5 score?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
The report specifies that the lesion is not compared against an earlier study.
psa_trend
The PSA velocity of 1.17 ng/mL/yr indicates a rapid increase in PSA over the measured period.
previous_notes
The management context regarding the prior biopsy status is that it was "None" and the surveillance protocol involved commissioning an mpMRI to define glandular architecture.

WHAT I DID NOT OPEN
laboratory_results, family-history anamnesis.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS 5 score as per the EAU guideline threshold for biopsy.
Rapid PSA velocity of 1.17 ng/mL/yr as a factor in the guideline matrix.
AGAINST sampling this patient now
Prior biopsy history is "None", which is a factor that supports sampling, but the guideline suggests considering other factors.

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: INDETERMINATE (uncertain). Last value 7.93 ng/mL over 5 points spanning 25 months; velocity +0.81 ng/mL per year; no meaningful doubling time.
PROJECTION at 6 months: 9.7 ng/mL, conformal 95% band 2.8-33.9.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.82
  uncertainty  +/- 0.06 epistemic (95% band 0.71-0.93), of which 0.00 comes from values that had to be imputed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

What moved me most across the labelled series: prior positive biopsy, no prior biopsy, free PSA < 15%, DWI restriction in the report, lesion >= 15 mm in the report, suspicious DRE. Out-of-fold AUC 0.794. I am the only expert that has read the report's wording, and I still cannot see the prior grade or the
surveillance history: those are in the notes, and the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.87  ('firm' tier; weight 3.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.82  ('firm' tier, fusion_nolab; weight 4.5)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=1.00  (k=3 precedents; does not vote)
  EXPERT-COHORT      BIOPSY  (rule pirads_ge_3; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: cohort criterion (pirads_ge_3) — carried by EXPERT-COHORT.
PANEL ANSWER: BIOPSY. It matched the reading urologist in 24 of 24 labelled cases in exactly this situation (never biopsied).

Confidence the trace model expects here: clear. Weights it expects: bx=noted, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents retrieved by the registrar appear to have answered the moderator's questions. The `radiology_report` stated the lesion was not compared against an earlier study, and the `psa_trend` indicated a rapid increase in PSA velocity of 1.17 ng/mL/yr.

ALIGNMENT WITH THE PANEL
The retrieved findings align with the PANEL-PROTOCOL's answer of BIOPSY, as the PI-RADS 5 score (which is the basis for the cohort criterion) is a key factor, and the rapid PSA velocity is noted as a factor in the guideline matrix.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What does the radiology_report state regarding whether the lesion is compared against an earlier study? Answered: The report specifies that the lesion is not compared against an earlier study.
Q2. What does the psa_trend indicate regarding the PSA velocity in the context of the PI-RADS 5 score? Answered: The PSA velocity of 1.17 ng/mL/yr indicates a rapid increase in PSA over the measured period.

WHAT CARRIES WEIGHT, AND WHY
The PI-RADS 5 score is the most decisive variable as it directly triggers the cohort criterion which the panel protocol confirms. The PSA velocity of 1.17 ng/mL/yr is also important as it is noted as a factor in the guideline matrix used by the EAU.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with a biopsy based on the alignment between the high PI-RADS score and the rapid PSA velocity, which supports the panel's conclusion.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

74 y/o, biopsy-naive, PI-RADS 5 with PSA density 0.267 mandates biopsy. The PI-RADS 5 finding is the decisive factor, supported by the elevated PSA density. No prior biopsy grade is recorded, but the finding is new.

What carried weight: bx=noted, age=important, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
